T
Tao Zuo
Researcher at The Chinese University of Hong Kong
Publications - 112
Citations - 5250
Tao Zuo is an academic researcher from The Chinese University of Hong Kong. The author has contributed to research in topics: Microbiome & Gut flora. The author has an hindex of 24, co-authored 93 publications receiving 2640 citations. Previous affiliations of Tao Zuo include Duke University & Huazhong University of Science and Technology.
Papers
More filters
Journal ArticleDOI
Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
Tao Zuo,Fen Zhang,Grace Lui,Yun Kit Yeoh,Amy Li,Hui Zhan,Yating Wan,Arthur C.K. Chung,Chun Pan Cheung,Nan Chen,Christopher K C Lai,Zigui Chen,Eugene Y.K. Tso,Kitty S. C. Fung,Veronica L. Chan,Lowell Ling,Gavin M. Joynt,David S.C. Hui,Francis K.L. Chan,Paul K.S. Chan,Siew C. Ng +20 more
TL;DR: Fecal microbiota alterations were associated with fecal levels of SARS-CoV-2 and COVID-19 severity, and strategies to alter the intestinal microbiota might reduce disease severity.
Journal ArticleDOI
Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19.
Yun Kit Yeoh,Tao Zuo,Grace Lui,Fen Zhang,Qin Liu,Amy Li,Arthur C.K. Chung,Chun Pan Cheung,Eugene Y.K. Tso,Kitty S. C. Fung,Veronica L. Chan,Lowell Ling,Gavin M. Joynt,David S.C. Hui,Kai Ming Chow,Susanna So Shan Ng,Timothy Li,Rita W Y Ng,Terry Cheuk-Fung Yip,Grace Lai-Hung Wong,Francis K.L. Chan,Chun K. Wong,Paul K.S. Chan,Siew C. Ng +23 more
TL;DR: In this article, the authors investigated whether the gut microbiome is linked to disease severity in patients with COVID-19, and whether perturbations in microbiome composition, if any, resolve with clearance of the SARS-CoV-2 virus.
Journal ArticleDOI
The Gut Microbiota in the Pathogenesis and Therapeutics of Inflammatory Bowel Disease
Tao Zuo,Siew C. Ng +1 more
TL;DR: The deconvolution of the gut microbiota in IBD lays the basis for unveiling the roles of these various gut microbiota components in I BD pathogenesis and being conductive to instructing on future IBD diagnosis and therapeutics.
Journal ArticleDOI
Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19.
Tao Zuo,Qin Liu,Fen Zhang,Grace Lui,Eugene Y.K. Tso,Yun Kit Yeoh,Zigui Chen,Siaw Shi Boon,Francis K.L. Chan,Paul K.S. Chan,Siew C. Ng +10 more
TL;DR: Evidence is provided for active and prolonged ‘quiescent’ GI infection even in the absence of GI manifestations and after recovery from respiratory infection of SARS-CoV-2.
Journal ArticleDOI
Bacteriophage transfer during faecal microbiota transplantation in Clostridium difficile infection is associated with treatment outcome.
Tao Zuo,Sunny H. Wong,Kelvin Long-Yan Lam,Rashid N. Lui,Kitty K.T. Cheung,Whitney Tang,Jessica Y.L. Ching,Paul K.S. Chan,Martin C.W. Chan,Justin C Y Wu,Francis K.L. Chan,Jun Yu,Joseph J.Y. Sung,Siew C. Ng +13 more
TL;DR: In a preliminary study, CDI is characterised by enteric virome dysbiosis, and treatment response in FMT was associated with a high colonisation level of donor-derived Caudovirales taxa in the recipient, which may play a role in the efficacy of FMT in CDI.